Julie M Cunningham
Director, Department of Genotyping Shared Resource
College of Medicine Mayo Clinicï»¿, USA
Dr.Cunningham is the Director of the Genotyping Shared Resource GSR in the Advanced Genomic Technology Centre Mayo Clinic College of Medicine in Rochester Minnesota USA . Dr. Cunningham has directed the activities of this shared resource since 2004 charged at that time to bring the facility to a high throughput facility using cutting edge technology. The GSR supports genomic studies of Mayo Clinic investigators their collaborators and outside investigators. The laboratory provides genome wide genotyping for gene association and linkage based analyses targeted genotyping for SNPs and insertion/deletion polymorphisms epigenetic analyses and array CGH Studies both large and small may be accommodated; over 12000 GWAS samples were run in 2010. The GSR has contributed genotyping for several consortia including the Ovarian Cancer Association Consortia OCAC and Consortium of Investigators of Modifiers of BRCA1/2 CIMBA and is contributing to the genotyping of 40000 samples using the Illumina Collaborative Oncological Geneenvironment Study iCOGS custom Infinium SNP array. The GSR is a collaborative entity with expertise in genomics supporting several multimillion US grants during 2010The mission of the GSR is a continued commitment to provide the highest quality genotyping data using advanced technology to enhance the understanding of human disease improve health and promote excellence in patient care.
Dr. Cunningham mainly focuses on the research work related to elucidation of the genetic basis of disease. Her primary focus is the genetic basis of familial cancer, in particular, cancers of the colon, prostate, ovary, NHL and CLL, breast and pancreas. As director of the Genotyping Shared Resource, She also participate in a number of research projects including Parkinson’s Disease, Vaccine Research, Addiction and Pharmacogenetics. She works closely with individuals from biostatistics, epidemiology, and the Mayo Clinic Cancer and Genomics Centers.